Gillette Devyn D, Curry Heather M, Cremer Thomas, Ravneberg David, Fatehchand Kavin, Shah Prexy A, Wewers Mark D, Schlesinger Larry S, Butchar Jonathan P, Tridandapani Susheela, Gavrilin Mikhail A
Integrated Biomedical Graduate Program, The Ohio State University Columbus, OH, USA.
Department of Microbial Infection and Immunity, The Ohio State University Columbus, OH, USA ; Center for Microbial Interface Biology, The Ohio State University Columbus, OH, USA.
Front Cell Infect Microbiol. 2014 Apr 10;4:45. doi: 10.3389/fcimb.2014.00045. eCollection 2014.
Human monocyte inflammatory responses differ between virulent and attenuated Francisella infection.
A mixed infection model showed that the virulent F. tularensis Schu S4 can attenuate inflammatory cytokine responses to the less virulent F. novicida in human monocytes.
F. tularensis dampens inflammatory response by an active process.
This suppression may contribute to enhanced pathogenicity of F. tularensis. Francisella tularensis is a Gram-negative facultative bacterium that can cause the disease tularemia, even upon exposure to low numbers of bacteria. One critical characteristic of Francisella is its ability to dampen or subvert the host immune response. Previous work has shown that monocytes infected with highly virulent F. tularensis subsp. tularensis strain Schu S4 responded with a general pattern of quantitatively reduced pro-inflammatory signaling pathway genes and cytokine production in comparison to those infected with the less virulent related F. novicida. However, it has been unclear whether the virulent Schu S4 was merely evading or actively suppressing monocyte responses. By using mixed infection assays with F. tularensis and F. novicida, we show that F. tularensis actively suppresses monocyte pro-inflammatory responses. Additional experiments show that this suppression occurs in a dose-dependent manner and is dependent upon the viability of F. tularensis. Importantly, F. tularensis was able to suppress pro-inflammatory responses to earlier infections with F. novicida. These results lend support that F. tularensis actively dampens human monocyte responses and this likely contributes to its enhanced pathogenicity.
人类单核细胞在强毒力和减毒力的土拉弗朗西斯菌感染后的炎症反应有所不同。
混合感染模型显示,强毒力的土拉弗朗西斯菌舒S4菌株可减弱人类单核细胞对毒力较弱的新凶手弗朗西斯菌的炎症细胞因子反应。
土拉弗朗西斯菌通过一个活跃过程抑制炎症反应。
这种抑制作用可能有助于增强土拉弗朗西斯菌的致病性。土拉弗朗西斯菌是一种革兰氏阴性兼性细菌,即使接触少量细菌也可引发兔热病。弗朗西斯菌的一个关键特性是其抑制或颠覆宿主免疫反应的能力。先前的研究表明,与感染毒力较弱的相关新凶手弗朗西斯菌的单核细胞相比,感染强毒力的土拉弗朗西斯菌亚种土拉弗朗西斯菌舒S4菌株的单核细胞,其促炎信号通路基因和细胞因子产生的总体模式在数量上有所减少。然而,尚不清楚强毒力的舒S4菌株是仅仅在逃避还是在积极抑制单核细胞反应。通过使用土拉弗朗西斯菌和新凶手弗朗西斯菌的混合感染试验,我们表明土拉弗朗西斯菌可积极抑制单核细胞的促炎反应。额外的实验表明,这种抑制作用呈剂量依赖性,且依赖于土拉弗朗西斯菌的活力。重要的是,土拉弗朗西斯菌能够抑制对先前新凶手弗朗西斯菌感染的促炎反应。这些结果支持了土拉弗朗西斯菌可积极减弱人类单核细胞反应,这可能有助于其增强致病性。